IGI Labs Announces Submission Of Two More ANDAs - Quick Facts

IGI Laboratories To Present At 25th ROTH Conference; Webcast At 12:00 PM ET

IGI Laboratories Q4 12 Earnings Conference Call At 4:15 PM ET

Trade IG now with

6/29/2012 4:45 PM ET

IGI Laboratories Inc. (IG: Quote) announced that it has submitted two additional abbreviated new drug applications or ANDAs to the US FDA, bringing the company's total number of submissions to eight.

IGI President and CEO Charlie Moore said, "We have now submitted eight ANDAs to the US FDA in just over two years. Our development pipeline remains full and we are gaining efficiency with each new project. Our team continues to execute on the product development front, while simultaneously growing our contract formulation and manufacturing business."

The development of ANDA products has successfully been integrated into the Company's ongoing contract services business, IGI said.

Click here to receive FREE breaking news email alerts for IGI, Laboratories, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

<<Previous 69 Articles

Editors Pick

Germany Skirts Recession In Q1 As Consumer Spending Recovers

A rebound in consumer spending helped the German economy thwart recession in the first quarter of 2013, detailed data from the Federal Statistical Office revealed Friday. However, the continued fall in firms' fixed asset investment and extreme weather conditions stifled the recovery. Market research group GfK predicts further increase in consumer confidence in June.

Gap Profit Climbs 43%

Gap Inc. Thursday after the markets closed that its first quarter profit rose 43% from last year, helped by higher sales and improved margins. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly sales. At the same time, the company eaffirmed its fiscal year 2013 earnings outlook, which is below analysts' current consensus estimate.

Stocks Close Modestly Lower But Well Off Worst Levels - U.S. Commentary

After moving sharply lower at the start of trading on Thursday, stocks showed a substantial recovery attempt over the course of the trading day. The rebound came as upbeat housing data helped offset worries about the Federal Reserve. The major averages climbed well off their worst levels of the day but still ended the session in the red.